Evidence map›Paper›PMID 41504274›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2026

Clinical, Genetic, and Imaging Characteristics of SCA27B: Insights from a Large Dutch Cohort.

Teije H van Prooije, Maartje Pennings, Roderick P P W M Maas, Jeroen de Vries, Corien Verschuuren-Bemelmans, Vincent Odekerken, Sirwan K L Darweesh, Mark Huisman, Mayke Oosterloo, Arthur Buijink and 17 more

Abstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Teije H van ProoijeDepartment of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.
Maartje PenningsDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Roderick P P W M MaasDepartment of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.
Jeroen de VriesExpertise Center for Movement Disorders Groningen, Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands.
Corien Verschuuren-BemelmansDepartment of Genetics, University Medical Center Groningen, Groningen, The Netherlands.
Vincent OdekerkenDepartment of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.
Sirwan K L DarweeshDepartment of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.
Mark HuismanDepartment of Neurology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Mayke OosterlooDepartment of Neurology, Institute for Mental Health and Neuroscience (MHeNs), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Arthur BuijinkDepartment of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.
Jaron van de WardtDepartment of Neurology, Haaglanden Medical Center (HMC), The Hague, The Netherlands.
Els VanhoutteDepartment of Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Tsz Hang WongDepartment of Neurology and Clinical Neurophysiology, Martini Hospital, Groningen, The Netherlands.
Lisette KoensExpertise Center for Movement Disorders Groningen, Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0002-2864-4225
Eva de BoerDepartment of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
Judith van GaalenDepartment of Neurology, Rijnstate Hospital, Arnhem, The Netherlands.
Martijn BeudelDepartment of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-2488-7051
Dareia S RoosDepartment of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.
Jorrit I HoffDepartment of Neurology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Thimo CornelissenDepartment of Neurology, Tergooi Hospital, Hilversum, The Netherlands.
Meyke SchoutenDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Thatjana GardeichikDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Erica van der LooijDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Christine KleinInstitute of Neurogenetics, University of Lubeck and Universital Hospital Schleswig-Holstein, Lubeck, Germany.
Joanne TrinhInstitute of Neurogenetics, University of Lubeck and Universital Hospital Schleswig-Holstein, Lubeck, Germany.
Erik-Jan KamsteegDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Bart van de WarrenburgDepartment of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDeep intronic GAA repeat expansions in intron 1 of the FGF14 gene were identified in 2023 as cause of late-onset cerebellar ataxia. Since then, GAA-FGF14-related ataxia (SCA27B) has emerged as one of the most common genetic causes of late-onset cerebellar ataxia.

objectivesTo describe the clinical, genetic, and imaging features of a large Dutch cohort.

methodsThe Radboudumc genetic database was queried for GAA-FGF14 expansions ≥200. Repeat length was assessed using locus-spanning polymerase chain reaction (PCR), repeat-primed PCR, and PacBio sequencing. A subset was validated using Oxford Nanopore. Clinical and imaging data were retrospectively reviewed.

results127 individuals with GAA-FGF14 expansions ≥200 were identified; clinical data were available from 116, including 109 symptomatic and 7 asymptomatic/presymptomatic individuals. Fifteen individuals carried GAA

conclusionsCore SCA27B features emerge in those carrying GAA

Indexed as

Cerebellar AtaxiaAdultAgedCohort StudiesFemaleFibroblast Growth FactorsHumansMagnetic Resonance ImagingMaleMiddle AgedNetherlandsRetrospective StudiesTrinucleotide Repeat Expansionfibroblast growth factor 14Fibroblast Growth FactorsAtaxiaautosomal dominant cerebellar ataxiageneticrepeat expansion disordersSCA27B

Identifiers

PMID41504274
PMCPMC13067310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.